相关实验视频

Updated: Jan 17, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

具有KRAS G12突变的人类肺腺癌的整合性蛋白质特征揭示了分子致病的产生

Xinyu Shi¹, Liling Hu¹, Yongshi Huang²

¹MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.

Journal of advanced research

|September 16, 2025

概括

这项研究揭示了具有KRAS G12突变的肺腺癌 (LUAD) 的独特分子亚型,确定了KRAS G12C丰富亚型的潜在免疫治疗益处. 这些发现可以指导LUAD患者的分层和治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
蛋白质组学是指蛋白质组学.

背景情况:

综合蛋白质基因组研究为肺腺癌 (LUAD) 提供了临床见解.
了解具有KRAS G12突变的LUAD分子格局,需要进行全面的蛋白质组分析.

研究的目的:

为了描述具有KRAS G12突变变体的LUAD的蛋白质基因组概况.
阐明LUAD中KRAS G12突变的分子特征和潜在的治疗影响.

主要方法:

在9,479个固体瘤上进行了下一代测序 (NGS),其中包括3,523种肺癌.
在96名LUAD患者身上进行了蛋白质分析,使用液体染色学-并联质谱法 (LC-MS/MS).
通过多重免疫组织化学 (mIHC) 描述了瘤免疫微环境 (TIME),并使用近距离标记绘制了蛋白质-蛋白质相互作用 (PPI) 地图.

主要成果:

基因组分析显示,KRAS G12突变具有异质的KRAS告知突变特征,具有对KRAS G12突变的等位基因特异分辨率.
蛋白质基因分析在KRAS G12突变LUAD中发现了独特的分子特征和瘤进展的标志.
无监督聚类发现了三种亚型;免疫调节亚型 (S2) 显示了KRAS G12C丰富,攻击性特征和潜在的免疫治疗益处. 在KRAS G12C突变瘤中观察到免疫细胞透的增加. 邻近蛋白质组学确定SLC4A7是G12C变种免疫调节的潜在效应因子.

结论:

这项蛋白质基因组研究提供了对具有KRAS G12突变的LUAD分子特征的见解.
这些发现可能会为患者分层和LUAD的治疗策略提供信息,等待进一步的临床验证.

关键词:

在KRAS G12突变中.肺部腺癌是肺部的癌症.蛋白质组学研究研究

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...